Moderna (MRNA) Enterprise Value (2017 - 2026)
Moderna's (MRNA) quarterly Enterprise Value came in at -$5.2 billion in Q1 2026, up 12.89% year-on-year from -$4.6 billion in Q1 2025, and up 10.24% on a QoQ basis from -$5.8 billion in Q4 2025.
Moderna (MRNA) Enterprise Value (2017 - 2026) Analysis & Trends
Moderna (MRNA) has 10 years of Enterprise Value data on file, last reported at -$5.2 billion in Q1 2026.
- On a quarterly basis, Enterprise Value rose 12.89% year-over-year to -$5.2 billion in Q1 2026; TTM through Mar 2026 was -$5.2 billion, a 12.89% increase from a year earlier, with the FY2025 full-year figure at -$5.8 billion, up 17.45% from the prior year.
- Enterprise Value for Q1 2026 stood at -$5.2 billion, up from -$5.8 billion in the prior quarter.
- Over the last five years, Enterprise Value for MRNA reached as high as -$4.5 billion in Q3 2025 and fell as low as -$10.1 billion in Q1 2022.
- Historically, Enterprise Value has averaged -$7.5 billion across 5 years, with a median of -$7.9 billion in 2022.
- Across the five-year window, Enterprise Value tumbled 30.77% in 2022 and soared 39.55% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$9.9 billion in 2022, then grew by 13.11% to -$8.6 billion in 2023, then grew by 18.35% to -$7.0 billion in 2024, then increased by 17.45% to -$5.8 billion in 2025, then rose by 10.24% to -$5.2 billion in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$5.2 billion in Q1 2026, -$5.8 billion in Q4 2025, and -$4.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn | -5.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.21 Bn |
| Dec 31, 2025 | -5.80 Bn |
| Sep 30, 2025 | -4.50 Bn |
| Jun 30, 2025 | -5.13 Bn |
| Mar 31, 2025 | -5.98 Bn |
| Dec 31, 2024 | -7.03 Bn |
| Sep 30, 2024 | -6.87 Bn |
| Jun 30, 2024 | -8.49 Bn |
| Mar 31, 2024 | -8.52 Bn |
| Dec 31, 2023 | -8.60 Bn |
| Sep 30, 2023 | -7.57 Bn |
| Jun 30, 2023 | -8.46 Bn |
| Mar 31, 2023 | -8.92 Bn |
| Dec 31, 2022 | -9.90 Bn |
| Sep 30, 2022 | -8.35 Bn |
| Jun 30, 2022 | -7.90 Bn |
| Mar 31, 2022 | -10.12 Bn |
| Dec 31, 2021 | -10.73 Bn |
| Sep 30, 2021 | -8.91 Bn |
| Jun 30, 2021 | -7.99 Bn |